Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-Naive B Cell Malignancies”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Not applicableNot Yet RecruitingNCT07764601
What this trial is testing

R-MA-PD-1 Versus R-MA in Treatment-naive Primary CNS Lymphoma

Who this might be right for
Primary Central Nervous System LymphomaDiffuse Large B-Cell Lymphoma
WEI XU 58
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Very early researchNot Yet RecruitingNCT07335094
What this trial is testing

A Clinical Study of Humanized CD19 CAR-T Cells With TLR2 for the Treatment of Adult Patients With Naive B-Cell Acute Lymphoblastic Leukemia/Lymphoma Who Are Intolerant to Intensive Chemotherapy

Who this might be right for
B Lymphoblastic Leukemia/Lymphoma
Zhujiang Hospital 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02514083
What this trial is testing

A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
National Heart, Lung, and Blood Institute (NHLBI) 29
Testing effectiveness (Phase 2)Study completedNCT04508647
What this trial is testing

Ublituximab Followed by Response-driven Addition of Umbralisib for Treatment-naive Follicular or Marginal Zone Lymphoma

Who this might be right for
Marginal Zone LymphomaFollicular Lymphoma
University of Colorado, Denver 4
Not applicableLooking for participantsNCT05950997
What this trial is testing

A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLL

Who this might be right for
Chronic Lymphocytic Leukemia
The First Affiliated Hospital with Nanjing Medical University 89
Testing effectiveness (Phase 2)Study completedNCT02337829
What this trial is testing

Acalabrutinib in Patients With Relapsed/Refractory and Treatment naïve Deletion 17p CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Acerta Pharma BV 48
Testing effectiveness (Phase 2)Looking for participantsNCT05336812
What this trial is testing

Acalabrutinib in Combination With Venetoclax or Obinutuzumab for the Treatment of Treatment-naive Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT02910583
What this trial is testing

Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)

Who this might be right for
LeukemiaChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 323
Testing effectiveness (Phase 2)Active Not RecruitingNCT02911142
What this trial is testing

Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma

Who this might be right for
Primary Effusion LymphomaB-Cell Neoplasm
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Looking for participantsNCT06792825
What this trial is testing

HM2023-43:Ph 2 Trial of Tafasitamab With Lenalidomide+Rituximab in Treatment-naive FL and MZL

Who this might be right for
Follicular LymphomaMarginal Zone Lymphoma
Masonic Cancer Center, University of Minnesota 65
Large-scale testing (Phase 3)Looking for participantsNCT05018520
What this trial is testing

The Safety and Effectiveness of 4R-CHOP+4R vs 6R-CHOP+2R in Newly Diagnosed Patients With DLBCL in Low Risk

Who this might be right for
Diffuse Large B Cell Lymphoma
Ruijin Hospital 640
Testing effectiveness (Phase 2)Active Not RecruitingNCT04505254
What this trial is testing

Acalabrutinib and Obinutuzumab for the Treatment of Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
M.D. Anderson Cancer Center 60
Not applicableUnknownNCT05809180
What this trial is testing

Pro-miniCHOP-like Regimen for Treatment-naive Elderly Patients

Who this might be right for
Diffuse Large B Cell Lymphoma
The First Affiliated Hospital of Soochow University 35
Testing effectiveness (Phase 2)Study completedNCT01243190
What this trial is testing

Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Who this might be right for
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 44
Large-scale testing (Phase 3)Study completedNCT01722487
What this trial is testing

Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Pharmacyclics LLC. 269
Testing effectiveness (Phase 2)UnknownNCT00258336
What this trial is testing

Rituximab, Vaccine Therapy, and GM-CSF in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Favrille 56
Testing effectiveness (Phase 2)Study completedNCT02013817
What this trial is testing

CHAIROS Study A Study of MabThera/Rituxan (Rituximab) Maintenance Therapy in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) Naive to Chemotherapy

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 43
Testing effectiveness (Phase 2)UnknownNCT05940064
What this trial is testing

Prospective Clinical Study of ZPR Regimen in Elderly Treatment-naive Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Peng Liu 30
Not applicableNo Longer AvailableNCT04052854
What this trial is testing

A Single-Arm, Expanded Access Study of Zanubrutinib in Participants With B-cell Malignancies

Who this might be right for
Waldenström Macroglobulinemia
BeiGene
Next Page